Publications by authors named "Sean B Singer"
Article Synopsis
- De novo bullous pemphigoid (BP) is a rare but serious skin condition that can develop in patients receiving immune checkpoint inhibitors (ICIs) for cancer treatment, potentially leading to the need for stopping the therapy permanently.
- A study was conducted to identify risk factors for developing BP by comparing patients who experienced this condition after ICI treatment with those who did not, using data from major hospitals over a six-year period.
- The analysis examined various factors, including demographics and medical history, to assess their relationship to BP development, with the ultimate goal of improving patient care and treatment strategies in oncology.